Capmatinib (INC280) in patients (pts) with METex14-mutated advances NSCLC: an update from phase 2 GEOMETRY mono-1 study

J. Wolf, T. Seto, J. Y. Han, N. Reguart, E. B. Garon, H. J. Groen, D. S. W. Tan, T. Hida, M. de Jonge, S. Orlov, E. F. Smit, P. Souquet, J. Vansteenkiste, S. Le Mouhaer, A. Robeva, M. Waldron-Lynch, A. Balbin, L. Fairchild, M. Giovannini, R. S. Heist

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)S134-S134
Number of pages1
Publication statusPublished - Mar-2020

Cite this